Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (218)	11/28/2000 10:19:15 PM
From: Extra Pale	Respond to of 724

starting with 10 points I would subtract 7 off the top for minimal revenue growth over the last two years in the midst of a sea of expansion that likely lifts the leakiest of boats... next, subtract 4 points for stock price performance over the same period of time; seems this company could be sold for significant profit to some hungry investor group (perhaps SI bio junkies -g-) add back 3 points for the foresight to start a drug discovery group 5 years ago; subtract 2 points for not realizing the value of DGI; and finally, add 1 point for entertainment value. Total= 1